Meanwhile, RUNX2 expression was increased by increasing the expression of vascular endothelial growth factor, matrix metalloproteases (MMP2, MMP9, and MMP13), and bone sialoprotein (BSP) in breast cancer metastatic cells (Dowdy et al., 2010). The gene discussed is MMP13; the disease is breast carcinoma.